Leadership

Management

pietro-bersani
CEO

Pietro Bersani, CPA

Mr. Bersani has served as a member of our Board since June 2020. […]

Learn More

Mr. Bersani has served as a member of our Board since June 2020. The Company appointed Mr. Bersani Chief Executive Officer effective May 10, 2022. From January 2022 to May 2022, Mr. Bersani served as interim Chief Executive Officer. From April 2020 to January 2022, Mr. Bersani was a Partner with B2B CFO Partners, LLC, which provides strategic management advisory services to owners of privately held companies. From November 2019 to March 2020, he served as the President, and Chief Executive Officer of K.P. Diamond Eagle, Inc., a consulting firm specialized in development of innovative commercial and private aviation business models. He served as a Senior Director within Alvarez & Marsal’s Private Equity Performance Improvement Practice, LLP between August 2018 and October 2019. From October 206 to July 2018, he served as President and Chief Executive Officer of K.P. Diamond Eagle, Inc. Prior to those professional experiences, Mr. Bersani served as the Chief Financial Officer of Fuel Systems Solutions, Inc. between April 2011 and October 2016.  Mr. Bersani is a Certified Public Accountant and is also a Certified Public Auditor and a Chartered Certified Accountant in Italy where he developed a significant knowledge of US GAAP and IFRS. Mr. Bersani earned a BA and MA in Business Economics from L. Bocconi University, Italy.

Leonardo Mirandola
CSO/Interim COO

Leonardo Mirandola, PhD

Leonardo “Leo” Mirandola, Ph.D. was named Chief Scientific Officer in July 2022, having […]

Learn More

Leonardo “Leo” Mirandola, Ph.D. was named Chief Scientific Officer in July 2022, having served as the Company’s Vice President of Research & Development and Clinical Translation since September 2021. In May 2023, he was named Interim Chief Operations Officer.  His previous roles were Head of Clinical Translation from 2020 to 2021, and Director of Clinical Operations from 2018 to 2019, having joined the Company in 2016 as Executive Director of Research and Development (R&D). 

Dr. Mirandola is an expert in molecular immunology and immunotherapy research, having authored more than 100 publications including original research papers, abstracts, and book chapters. His studies have included, among other topics, breakthrough findings in the interactions between tumor cells and immune cells, primarily focusing on the tumor microenvironment, neoangiogenesis, cell signaling, and how they influence the development of new therapeutic strategies.  Additionally, Dr. Mirandola is the inventor of nine different patent-pending technologies ranging from tumor biomarker identification and validation to cancer vaccines and adoptive cell therapies.

Before joining Kiromic, Dr. Mirandola was a post-doctoral research scientist at Texas Tech University Health Sciences Center.

He earned an M.S. in Medical Biotechnologies and a Ph.D. in Molecular Medicine at the University of Milan.

Chief of Staff

Scott Dahlbeck, MD, PharmD

Dr. Dahlbeck has served as our Chief of Staff since February 2022. He […]

Learn More

Dr. Dahlbeck has served as our Chief of Staff since February 2022. He previously served as our President from January 2013 to October 2019, and Chief Medical Officer from October 2019 to February 2022. Dr. Dahlbeck is an expert in prostate cancer research and treatment and has served as a Radiation Oncologist for several cancer centers, including as an Adjunct Assistant Professor in Internal Medicine, Pathology, and Urology at the Texas Tech University Health Sciences Center. Dr. Dahlbeck has also patented, manufactured, and commercialized IP and has more than a decade of experience in medical and oncology commerce.

Dr. Dahlbeck earned an MD from the University of Texas Health Science Center at Houston, completed residencies in family practice and radiation oncology, and earned a PharmD degree from the University of Nebraska Medical Center, College of Pharmacy.

brian-hungerford
CFO

Brian Hungerford

Brian Hungerford is a Chartered Global Management Accountant (CGMA), Certified Public Accountant (CPA) […]

Learn More

Brian Hungerford is a Chartered Global Management Accountant (CGMA), Certified Public Accountant (CPA) and a former executive with over 20 years of experience in a wide range of industries.

Mr. Hungerford served large public companies, such as Constellation Energy Group, Dynegy, and Merrill Lynch-Bank of America. He also worked with private companies, such as Mercuria Energy Group, a global energy trader, and Windstar LPG—a multi-national transportation and logistics firm. Throughout his career, Mr. Hungerford gained significant experience in SEC reporting, project management, process improvements, systems design & implementation, and automation. Mr. Hungerford is also certified in Lean Six Sigma.

Mr. Hungerford began his career in the finance industry as an accountant, working for Halliburton and BP. He later took an opportunity to transition into public accounting and began working at Deloitte in their Global Energy Markets practice, specializing in derivatives and technical accounting as an auditor and consultant for three years. 


Corporate Board of Directors

michael-nagel
Chairperson

Michael Nagel

Learn More

Mr. Nagel has served as a member of our board of directors since June 2020. He has over 30 years of sales and marketing experience in the medical device industry. Since 2012, Mr. Nagel has served as the President and CEO of Vomaris Innovations, Inc, which specializes in wireless microcurrent-generating technologies that are focused on regeneration, healing, and recovery. Previously, Mr. Nagel served as the Chief Commercial Officer of Neomend, a biomaterial company that developed ProGel, a PMA approved surgical sealant for lung surgery. From 1997 to 2005, Mr. Nagel also served as Co-Founder and Vice President of Worldwide Sales and Marketing at Vascular Solutions (VASC).

In addition to Mr. Nagel’s executive experience, he also serves as a director for Franklin Mountain Medical, LLC an early stage company in the structural heart market. Mr. Nagel holds both a B.A. in Business and a M.B.A. from the University of St. Thomas.

Michael-Catlin
Independent Director

Michael Catlin

Learn More

Mr. Catlin has more than 38 years of Information Technology (IT) experience in the finance and aerospace sectors and has served as a member of audit and various risk and security committees. He has experience in cybersecurity, IT operations, IT risk, and software development. He retired from Capital Group as a Senior Vice President at the end of 2022. In addition, he was the Chairperson of the Investment Company Institute Chief Information Security Officer committee.

Mr. Catlin began his career as a software developer, where he gained experience in the development of accounting, financial, and program management systems. After joining Capital Group in 1994, he took on leadership roles with increasing responsibility in Application Development and Infrastructure. As a Senior Vice President, he was Chief Information Security Officer (CISO) and Head of Technology Infrastructure.

Mr. Catlin has been a speaker at various industry forums on cybersecurity, technology, and risk management. He holds an M.S. in Computer Science and a B.S. in Business Computer Methods from the California State University system.

pietro-bersani
Director

Pietro Bersani, CPA

Learn More

Mr. Bersani has served as a member of our Board since June 2020. The Company appointed Mr. Bersani Chief Executive Officer effective May 10, 2022. From January 2022 to May 2022, Mr. Bersani served as interim Chief Executive Officer. From April 2020 to January 2022, Mr. Bersani was a Partner with B2B CFO Partners, LLC, which provides strategic management advisory services to owners of privately held companies. From November 2019 to March 2020, he served as the President, and Chief Executive Officer of K.P. Diamond Eagle, Inc., a consulting firm specialized in development of innovative commercial and private aviation business models. He served as a Senior Director within Alvarez & Marsal’s Private Equity Performance Improvement Practice, LLP between August 2018 and October 2019. From October 206 to July 2018, he served as President and Chief Executive Officer of K.P. Diamond Eagle, Inc. Prior to those professional experiences, Mr. Bersani served as the Chief Financial Officer of Fuel Systems Solutions, Inc. between April 2011 and October 2016.  Mr. Bersani is a Certified Public Accountant and is also a Certified Public Auditor and a Chartered Certified Accountant in Italy where he developed a significant knowledge of US GAAP and IFRS. Mr. Bersani earned a BA and MA in Business Economics from L. Bocconi University, Italy.

Pam-Misajon
Independent Director

Pam Misajon

Learn More

Ms. Misajon recently joined the board of directors in July, 2023. She has extensive experience in the medical device regulated industry at both start-ups and at established public companies. Ms. Misajon currently holds the position of Chief Compliance Officer and Vice President of Regulatory, Quality and Operations at Suneva Medical, Inc. She has held prior executive leadership positions in the areas of Regulatory Affairs, Quality Assurance, and Clinical studies. Ms. Misajon holds a Bachelor of Arts degree in Management from the University of Phoenix.

Copyright © 2024 Kiromic BioPharma, Inc. All rights reserved.